Trial intelligence / Profile preview

Ultrasound-guided ropivacaine injection for pain in thoracic outlet syndrome

RBR-4dx8n4Phase 4Completed

Sponsor
IMREA HCFMUSP
Start
Jul 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ropivacaine in thoracic outlet syndrome (TOS) (2 arms), sponsored by IMREA HCFMUSP. Started Jul 2012; status: completed.

02

Drugs

ropivacaine
03

Conditions

thoracic outlet syndrome (TOS)

Beyond the preview

Go deeper on RBR-4dx8n4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4dx8n4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call